^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-07062119

    i
    Other names: PF-07062119, PF 07062119
    Associations
    News
    Trials
    Company:
    Pfizer
    Drug class:
    CD3 agonist, GUCY2C inhibitor
    Related drugs:
    Associations
    News
    Trials